A Trial of HR17031 Injection With Renal Insufficiency
Status:
Not yet recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This study used a single-dose, open design to compare the pharmacokinetics of subjects with
mild, moderate and severe renal insufficiency and end-stage renal disease and subjects with
normal renal function.